Skip to main content

Hit enter to search or ESC to close

Home
Services
Label Comprehension Studies
Self-Selection Studies
Actual Use Studies
International Consumer Behavior Studies

Menu

Monthly Archives

March 2023

FDA Approves First-In-Class OTC Naloxone Nasal Spray!

Uncategorized

FDA Approves First-In-Class OTC Naloxone Nasal Spray!

Address: 331 S Rio Grande St, Suite 100
Salt Lake City, UT 84101
Phone: (801) 487-9899
Email: info@pegus.com
Employment Opportunities: Visit this link

About Us

We are a unique, full-service OTC consumer behavior research organization. We specialize in the label comprehension, self-selection, and actual use studies that lead to successful OTC approval. We provide expert, end-to-end support for Drug Facts Label development and testing, including consulting, support for FDA interactions, protocol design, study conduct, site selection and management, monitoring, data management, statistics, medical writing and submission-ready data (CDISC) services.

Recent News

Katie Montenegro Promoted to Associate VP Project Management January 3, 2025
FDA Approves First-In-Class OTC Contraceptive! July 13, 2023
FDA Approves First-In-Class OTC Naloxone Nasal Spray! March 29, 2023
New Staff February 8, 2023

Quick Links

Home

© PEGUS Research 2024. All Rights Reserved.
Designed, developed, and hosted by

View our Website Privacy Policy, Study Privacy Notice and our Messaging Terms and Conditions

,

facebook
linkedin

Home
Services
Label Comprehension Studies
Self-Selection Studies
Actual Use Studies
International Consumer Behavior Studies

Address:
331 S Rio Grande St, Suite 100
Salt Lake City, UT 84101
Phone:
(801) 487-9899
Email:
info@pegus.com

facebook
linkedin

casibom giriş marsbahis giriş jojobet giriş Jojobet Casibom Giriş Jojobet Giriş Holiganbet Giriş